mnexspike moderna - Search News

News

Moderna Stock Climbs

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that puts them at high risk.

Medical Xpress · 7h

Moderna's new lower-dose COVID-19 vaccine approved by FDA

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

10hon MSN

RFK Jr. says Moderna agreed to another clinical trial to support new COVID shot

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved ...

FOX 35 Orlando2d

FDA approves Moderna's new lower-dose COVID-19 vaccine

Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results